Skip to Content Facebook Feature Image

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market

Business

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market
Business

Business

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market

2026-06-17 20:01 Last Updated At:20:21

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Jun 17, 2026--

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Bortezomib for Injection in the United States. The product contains the same active ingredient as VELCADE ®, as approved by the U.S. Food and Drug Administration, and is indicated for the treatment of adults with multiple myeloma and mantle cell lymphoma. Bortezomib for Injection is available as a carton of one 3.5 mg single-dose vial.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617268531/en/

In line with Avenacy’s mission to champion patient safety and streamline patient care, Bortezomib for Injection will feature the Company’s highly differentiated packaging and labeling to support accurate medication selection.

Avenacy will begin shipping Bortezomib for Injection to wholesale partners this week. The Company is supported by a global network of development and contract manufacturing partners that have undergone successful FDA inspections based on cGMP standards.

U.S. sales of Bortezomib for Injection were approximately $43 million for the twelve months ending in March 2026.¹

Indications

Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

Contraindications

Bortezomib for Injection is contraindicated in patients with hypersensitivity (not including local reactions) to bortezomib, boron, or mannitol. Reactions have included anaphylactic reactions.

Bortezomib for Injection is contraindicated for intrathecal administration. Fatal events have occurred with intrathecal administration of Bortezomib for Injection.

Please see link for Full Prescribing Information.

VELCADE ® is a registered trademark of Millennium Pharmaceuticals, Inc.

¹ Source: IQVIA

About Avenacy

Avenacy is a U.S.-based specialty pharmaceutical company focused on supplying critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products in order to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications.

Avenacy was launched in 2023 and is headquartered in Schaumburg, IL. For more information, please visit Avenacy.

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market

RIVERHEAD, N.Y. (AP) — After decades waiting for justice, relatives of women murdered by New York’s Gilgo Beach serial killer laid into him Wednesday as he faced sentencing for his admitted crimes.

“You fill me with so much repugnance, I can’t stand it,” Jasmine Robinson, a cousin of victim Jessica Taylor, told killer Rex Heuermann.

Hands clasped and resting on the defense table in an eastern Long Island courtroom, Heuermann looked straight ahead and lightly tapped his fingers. The Long Island architect, who lived a secret life of violence for years before admitting he killed eight women, faces the likelihood of a life sentence.

“A million years isn’t enough,” Robinson said. “Nothing will ever make this right.”

Amanda Funderburg, victim Melissa Barthelemy's sister, urged Heuermann to look at her as she spoke.

He glanced in her direction, but his eyes were slightly downcast.

“I hope you suffer,” said Funderburg, who recounted getting a taunting phone call from him days after Barthelemy disappeared, when Funderburg was 15 years old.

The sentencing caps an extraordinary investigation that solved one of New York's most perplexing mysteries — one that began as a series of seemingly unconnected and largely unmarked disappearances of young women, but became the focus of true-crime documentaries, books and podcasts after police began discovering the victims' skeletal remains in the sandy scrub along a coastal parkway.

“Justice has been done, but it can’t replace what has been taken,” said JoAnn Mack, the mother of victim Valerie Mack. “She had dreams, and you took them all away from her.”

Heuermann, who has remained largely silent through multiple court appearances since his 2023 arrest, will also have a chance to speak Wednesday. His ex-wife and two grown children weren't at the sentencing, having said through their lawyers that they'd stay away out of respect for the victim’s families.

Heuermann, 62, pleaded guilty in April to charges that he murdered seven women: Barthelemy, Mack, Taylor, Megan Waterman, Amber Lynn Costello, Maureen Brainard-Barnes, and Sandra Costilla.

Heuermann also admitted in court to killing an eighth victim, Karen Vergata, though he was never charged in her death. He said he strangled his victims, many of them sex workers, and dismembered some of their bodies.

Brainard-Barnes’ two children, who were 7 and 1 when she disappeared, underscored Wednesday how her absence shaped their lives and how she never got to know the adults they grew up to be. Her sister, Melissa Cann, said she lived with “survivor’s guilt” for decades, wondering whether she could have done something more to protect Brainard-Barnes.

“It was a weight I carried everywhere,” Cann said, sobbing deeply. But, she said, that guilt is “not mine to carry. It is for Rex and Rex alone.”

Liliana Waterman was 3 when her mother, Megan Waterman, vanished. The daughter said she didn’t fully understand what had happened until she was about 9.

“In an instant, my world was shattered,” she said. “Was she in pain? Was she scared?”

Most of the women disappeared between 2000 and 2010, and most of their remains were found on a parkway not far from Long Island’s Gilgo Beach, some 50 miles (80 kilometers) from Manhattan.

Costilla’s remains were found in 1993, more than 60 miles (100 kilometers) away in the Hamptons, while Vergata’s remains were found in 1996 on Fire Island, more than 20 miles (32 kilometers) east of Gilgo Beach.

The case spilled into view in 2010, when investigators started to find remains along Ocean Parkway while looking into the disappearance of another sex worker, Shannan Gilbert, whose death was ultimately ruled an accidental drowning.

The case went cold until 2022, when detectives linked Heuermann to a pickup truck that a witness reported seeing when one of the victims disappeared in 2010.

Eventually, they matched DNA from a pizza crust Heuermann discarded in a Manhattan trash can to genetic material extracted from highly degraded hair fragments found on the women’s remains.

Investigators amassed other evidence, including cellphone and tracking data showing Heuermann arranged meetings with some victims shortly before their disappearances. After Heuermann's arrest, prosecutors recovered what they described as a “blueprint” for the killings from his computer files.

As part of his guilty plea, Heuermann agreed to cooperate with the FBI’s behavioral analysis unit to help catch other serial killers.

Heuermann has spent the past three years alone in a segregated cell at the Suffolk County jail, reading crime novels, occasionally being visited by his lawyers or family, and striking up a brief correspondence with the infamous “Happy Face Killer,” according to Sheriff Errol Toulon.

Follow Philip Marcelo at https://x.com/philmarcelo. Associated Press writer Jennifer Peltz in New York contributed.

Defense Attorney for convicted murderer Rex Heuermann, Michael J. Brown, arrives to the the Arthur M. Cromarty Criminal Court Complex ahead Heuermann's court sentencing Wednesday, June 17, 2026, in Suffolk County, New York. (AP Photo/Ryan Murphy)

Defense Attorney for convicted murderer Rex Heuermann, Michael J. Brown, arrives to the the Arthur M. Cromarty Criminal Court Complex ahead Heuermann's court sentencing Wednesday, June 17, 2026, in Suffolk County, New York. (AP Photo/Ryan Murphy)

Natile Dilea, a member of a sex-workers rights group, stands in line to enter the Arthur M. Cromarty Criminal Court Complex ahead of a court sentencing for convicted murderer, Rex Heuermann, Wednesday, June 17, 2026, in Suffolk County, New York. (AP Photo/Ryan Murphy)

Natile Dilea, a member of a sex-workers rights group, stands in line to enter the Arthur M. Cromarty Criminal Court Complex ahead of a court sentencing for convicted murderer, Rex Heuermann, Wednesday, June 17, 2026, in Suffolk County, New York. (AP Photo/Ryan Murphy)

Members of a sex-workers rights group, hug each other while waiting in line to enter the Arthur M. Cromarty Criminal Court Complex ahead of a court sentencing for convicted murderer, Rex Heuermann, Wednesday, June 17, 2026, in Suffolk County, New York. (AP Photo/Ryan Murphy)

Members of a sex-workers rights group, hug each other while waiting in line to enter the Arthur M. Cromarty Criminal Court Complex ahead of a court sentencing for convicted murderer, Rex Heuermann, Wednesday, June 17, 2026, in Suffolk County, New York. (AP Photo/Ryan Murphy)

Recommended Articles